Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
Portfolio Pulse from
Biomerica, Inc. announced that its inFoods® IBS blood test can significantly alleviate abdominal pain in IBS patients when used to guide dietary therapy. Clinical trial results were published in the journal Gastroenterology.
February 19, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biomerica's inFoods® IBS test has been shown to significantly reduce IBS symptoms, according to a clinical trial published in Gastroenterology. This could enhance the company's market position and drive stock price appreciation.
The publication of positive clinical trial results in a leading medical journal is likely to boost investor confidence in Biomerica's product, potentially increasing demand and sales. This could lead to a positive impact on BMRA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100